DE69314586D1 - Arzneimittelzusammensetzung enthaltend TCF-II - Google Patents

Arzneimittelzusammensetzung enthaltend TCF-II

Info

Publication number
DE69314586D1
DE69314586D1 DE69314586T DE69314586T DE69314586D1 DE 69314586 D1 DE69314586 D1 DE 69314586D1 DE 69314586 T DE69314586 T DE 69314586T DE 69314586 T DE69314586 T DE 69314586T DE 69314586 D1 DE69314586 D1 DE 69314586D1
Authority
DE
Germany
Prior art keywords
composition containing
medicament composition
tcf
containing tcf
derived
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69314586T
Other languages
English (en)
Other versions
DE69314586T2 (de
Inventor
Hiroaki Masunaga
Nobuaki Fujise
Kanji Higashio
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Atlas Pharmaceuticals Inc Sunnyvale Calif Us
Original Assignee
Snow Brand Milk Products Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from JP21222792A external-priority patent/JP3619526B2/ja
Priority claimed from JP21222992A external-priority patent/JP3380573B2/ja
Priority claimed from JP4234198A external-priority patent/JPH0656692A/ja
Application filed by Snow Brand Milk Products Co Ltd filed Critical Snow Brand Milk Products Co Ltd
Application granted granted Critical
Publication of DE69314586D1 publication Critical patent/DE69314586D1/de
Publication of DE69314586T2 publication Critical patent/DE69314586T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/18—Growth factors; Growth regulators
    • A61K38/1833—Hepatocyte growth factor; Scatter factor; Tumor cytotoxic factor II
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Immunology (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Zoology (AREA)
  • Surgery (AREA)
  • Dermatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
DE69314586T 1992-07-16 1993-07-16 Arzneimittelzusammensetzung enthaltend TCF-II Expired - Fee Related DE69314586T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP21222792A JP3619526B2 (ja) 1992-07-16 1992-07-16 Ｔｃｆ−ｉｉを有効成分とする肝臓疾患治療剤
JP21222992A JP3380573B2 (ja) 1992-07-16 1992-07-16 Ｔｃｆ−ｉｉを有効成分とする蛋白合成促進剤
JP4234198A JPH0656692A (ja) 1992-08-10 1992-08-10 Ｔｃｆ−ｉｉを有効成分とする創傷治療剤

Publications (2)

Publication Number Publication Date
DE69314586D1 true DE69314586D1 (de) 1997-11-20
DE69314586T2 DE69314586T2 (de) 1998-02-19

Family

ID=27329338

Family Applications (3)

Application Number Title Priority Date Filing Date
DE69334281T Expired - Fee Related DE69334281D1 (de) 1992-07-16 1993-07-16 TCF-II enthaltende medizinische Zusammensetzung
DE69334087T Expired - Fee Related DE69334087T2 (de) 1992-07-16 1993-07-16 Arzneimittelzusammensetzung enthaltend TCF-II
DE69314586T Expired - Fee Related DE69314586T2 (de) 1992-07-16 1993-07-16 Arzneimittelzusammensetzung enthaltend TCF-II

Family Applications Before (2)

Application Number Title Priority Date Filing Date
DE69334281T Expired - Fee Related DE69334281D1 (de) 1992-07-16 1993-07-16 TCF-II enthaltende medizinische Zusammensetzung
DE69334087T Expired - Fee Related DE69334087T2 (de) 1992-07-16 1993-07-16 Arzneimittelzusammensetzung enthaltend TCF-II

Country Status (7)

Country Link
EP (3) EP0821969B1 (de)
KR (1) KR100271087B1 (de)
AT (3) ATE345809T1 (de)
CA (1) CA2100720C (de)
DE (3) DE69334281D1 (de)
DK (2) DK0588477T3 (de)
ES (2) ES2276409T3 (de)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU674871B2 (en) * 1992-07-16 1997-01-16 Atlas Pharmaceuticals Inc. Blood coagulation normalizer containing TCF-II as active ingredient
JP3402476B2 (ja) * 1992-08-24 2003-05-06 生化学工業株式会社 リポ多糖結合性タンパク質及びその製造法
JP3680114B2 (ja) * 1993-09-17 2005-08-10 敏一 中村 脳神経障害治療剤
JPH08176007A (ja) * 1994-12-27 1996-07-09 Snow Brand Milk Prod Co Ltd 脂質代謝異常治療剤
JP4006058B2 (ja) * 1997-03-11 2007-11-14 第一三共株式会社 多臓器不全予防及び／又は治療剤
ZA982068B (en) 1997-03-14 1998-09-16 Snow Brand Milk Products Co Ltd Agent for preventing and/or treating cachexia
JP3961064B2 (ja) * 1997-03-28 2007-08-15 第一製薬株式会社 腎疾患予防及び／又は治療剤
JPH1129493A (ja) * 1997-07-14 1999-02-02 Snow Brand Milk Prod Co Ltd 放射線障害予防及び／又は治療剤
JPH11269091A (ja) * 1998-03-19 1999-10-05 Snow Brand Milk Prod Co Ltd 敗血症予防及び／又は治療剤

Family Cites Families (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3904753A (en) * 1970-02-20 1975-09-09 Research Corp Clinically active bovine growth hormone fraction
JPS58146293A (ja) 1982-02-26 1983-08-31 Mochida Pharmaceut Co Ltd 抗腫瘍性糖蛋白質の製造方法
US4708948A (en) 1984-04-20 1987-11-24 The United States Of America As Represented By The Department Of Health And Human Services Substantially purified tumor growth inhibitory factor
DE3419184A1 (de) 1984-05-23 1985-11-28 Dr.Ing.H.C. F. Porsche Ag, 7000 Stuttgart Zuendverteileranordnung an brennkraftmaschinen
JPS62103021A (ja) 1985-10-28 1987-05-13 Yoshitomi Pharmaceut Ind Ltd 細胞障害作用を有する生理活性物質およびその製造方法
JP2564486B2 (ja) * 1986-07-14 1996-12-18 修治 橋本 肝細胞増殖因子
JPS6410998A (en) 1986-12-22 1989-01-13 Green Cross Corp Tumor cell inhibitory factor
NZ232813A (en) * 1989-03-10 1992-08-26 Snow Brand Milk Products Co Ltd Human fibroblast glycoprotein, cell differentiation, blood vessel endothelial cell growth factor, cellular immunology inforcing factor of 78 or 74 thousand daltons plus or minus two thousand daltons
US5035887A (en) * 1989-09-07 1991-07-30 Institute Of Moelcular Biology, Inc. Wound healing composition of IL-1 and PDGF or IGF-1
DE69130494T2 (de) * 1990-06-11 1999-07-08 Toshikazu Nakamura Rekombinanter menschlicher Hepatozytwachstumsfaktor und Verfahren zu seiner Herstellung
KR0153009B1 (ko) 1990-07-13 1998-10-15 카츄아 쇼노 티씨에프-ii의 아미노산 서열을 암호하는 dna를 함유한 플라스미드 형질전환세포 및 이것을 사용하여 생리 활성물질을 생산하는 방법

Also Published As

Publication number Publication date
DK0821969T3 (da) 2007-03-26
KR940005286A (ko) 1994-03-21
CA2100720A1 (en) 1994-01-17
KR100271087B1 (en) 2000-11-01
AU4194593A (en) 1994-01-20
ATE428438T1 (de) 2009-05-15
ATE345809T1 (de) 2006-12-15
EP0588477A2 (de) 1994-03-23
ES2110057T3 (es) 1998-02-01
EP1719522A1 (de) 2006-11-08
EP1719522B1 (de) 2009-04-15
ES2276409T3 (es) 2007-06-16
DE69334087T2 (de) 2007-07-05
DE69334281D1 (de) 2009-05-28
AU673835B2 (en) 1996-11-28
CA2100720C (en) 2003-03-11
DE69314586T2 (de) 1998-02-19
EP0588477A3 (en) 1994-05-25
EP0821969A3 (de) 2000-12-13
EP0821969B1 (de) 2006-11-22
ATE159171T1 (de) 1997-11-15
EP0588477B1 (de) 1997-10-15
DE69334087D1 (de) 2007-01-04
DK0588477T3 (da) 1998-03-30
EP0821969A2 (de) 1998-02-04

Similar Documents

Publication Publication Date Title
NO20004282D0 (no) Matriksproteinpreparater for sÕrheling
ATE243196T1 (de) Piperidine und pyrrolidine
MX9708800A (es) Compuestos biciclicos aromaticos.
DE68913739T2 (de) Kosmetische und hautbehandlungs-zusammensetzungen.
ATE200661T1 (de) Bisaromatische verbindungen, sie enthaltende pharmazeutische und kosmetische zusammensetzungen und verwendungen
BR9813318A (pt) Processo de tratamento de tumores e degeneração macular em paciente humano ou veterinário, composição farmacêutica para tratamento de tumores e degeneração macular em um paciente humano ou veterinário
MX9708803A (es) Compuestos biaromaticos de propinilo o dienilo.
DE69314586T2 (de) Arzneimittelzusammensetzung enthaltend TCF-II
IT1240683B (it) Composizione farmaceutica contenente egf
GR3032224T3 (en) Therapeutic agent for threatened abortion.
ATE5256T1 (de) Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
BG103905A (en) New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine
DE3687233T2 (de) Pharmazeutische zusammensetzungen zur behandlung von hautkrankheiten.
DE68905076D1 (de) Pharmazeutische zusammensetzung fuer die behandlung von hautwunden.
TR199901385T2 (xx) Piperidin t�revleri.
DE69330809D1 (de) Therapeutisches Agens für Neutropenie
DE69719190D1 (de) Kolostrum enthaltende pharmazeutische zusammensetzungen und deren verwendung
KR930703003A (ko) 피부질환치료용 제약 조성물
ZA979135B (en) New cosmetic, dermopharmaceutical or veterinary compositions for the antiseptic treatment of human or animal skin.
ATE102478T1 (de) Kosmetische und hautbehandlungszusammensetzungen.

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8327 Change in the person/name/address of the patent owner

Owner name: DAIICHI PHARMACEUTICAL CO., LTD., TOKIO/TOKYO, JP

8327 Change in the person/name/address of the patent owner

Owner name: ATLAS PHARMACEUTICALS, INC., SUNNYVALE, CALIF., US

8339 Ceased/non-payment of the annual fee